Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Preeclampsia is an obstetric disorder that affects 3-8% of pregnant women and remains a leading cause of short- and long-term neonatal and maternal morbidity and mortality. Professional societies recommend the use of low dose aspirin to prevent preeclampsia in high-risk women. However, interest in prevention of this disease and better understanding of its pathophysiology have led to growing research on other agents. This review focuses on the main therapeutic agents evaluated or in use for preeclampsia prevention. © 2020 Elsevier Ltd. All rights reserved.

Citation

Marwan Ma'ayeh, Maged M Costantine. Prevention of preeclampsia. Seminars in fetal & neonatal medicine. 2020 Oct;25(5):101123


PMID: 32513597

View Full Text